Manz, Kirsi; Nennstiel, Uta; Marzi, Carola; Mansmann, Ulrich; Brockow, Inken (2025): Quality measures of two-stage newborn hearing screening: systematic review and meta-analysis. Frontiers in Public Health, 13: 1566478. ISSN 2296-2565
![fpubh-1-1566478.pdf [thumbnail of fpubh-1-1566478.pdf]](https://oa-fund.ub.uni-muenchen.de/style/images/fileicons/text.png)
fpubh-1-1566478.pdf
Die Publikation ist unter der Lizenz Creative Commons Namensnennung (CC BY) verfügbar.
Herunterladen (5MB)
Abstract
Introduction:
Newborn screening for hearing impairment (NHS) is a crucial public health issue worldwide. Often, a two-stage screening with two different testing approaches is used. We aimed to investigate the optimal screening algorithm, based on data from the literature published in the last 30 years. A particular focus of the study was to synthesize the existing evidence on two-stage newborn hearing screening regarding the refer rate (RFR), the percentage of children that did not pass the second test or were lost after the first test.
Methods:
We searched MEDLINE and Scopus for studies on two-stage NHS using transient evoked otoacoustic emissions (TEOAE) or automated auditory brainstem response (AABR). All studies on newborns who received their first test as an inpatient and a second test up to 1 month later were eligible. Random effects meta-analysis was performed to estimate RFR. Risk of bias was assessed using QUADAS-II. The unfunded study was registered in PROSPERO (CRD42023403091, available at https://www.crd.york.ac.uk/PROSPERO/view/CRD42023403091).
Results:
Eighty-five study protocols, including over 1,120,000 newborns, met the inclusion criteria. Certainty in the evidence was rated as moderate.
Discussion:
Strategies that did not involve changes to the screening method had a lower RFR. AABR-AABR: RFR = 1.3% [95% confidence interval (CI): 0.9, 1.8%], TEOAE-TEOAE: RFR = 2.7% (CI: 2.2, 3.2%), TEOAE-AABR: RFR = 3.9% (CI: 2.9, 5.1%), AABR-TEOAE: 5.9% (CI: 5.0, 6.9%). Consequently, where feasible, changing the screening method at the second screening should be avoided in order to minimize the number of follow-up examinations.
Dokumententyp: | Artikel (LMU) |
---|---|
Organisationseinheit (Fakultäten): | 07 Medizin > Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie |
DFG-Fachsystematik der Wissenschaftsbereiche: | Lebenswissenschaften |
Veröffentlichungsdatum: | 15. Mai 2025 10:54 |
Letzte Änderung: | 15. Mai 2025 10:57 |
URI: | https://oa-fund.ub.uni-muenchen.de/id/eprint/1865 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 491502892 |